市值低于现金的企业，是机会吗_老虎社区_美港股上老虎

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":170308958,"tweetId":"170308958","gmtCreate":1626402275174,"gmtModify":1626402275174,"author":{"id":3452938437060827,"idStr":"3452938437060827","authorId":3452938437060827,"authorIdStr":"3452938437060827","name":"牛唐","avatar":"https://static.tigerbbs.com/de2e2f2e2676bc8463b050f4e3ff17d2","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"社区优质创作者：发表过3篇及以上精华帖，且30天内发表过至少一篇精华帖并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.11.03","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"}}],"fanSize":6284,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"市值低于现金的企业，是机会吗","extraTitle":"","html":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a>&nbsp;市值37亿美元，账上有近50亿欧元。股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。<a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a>&nbsp;</body></html>","htmlText":"<html><head></head><body><a target=\"_blank\" href=\"https://laohu8.com/S/GLPG\">$Galapagos NV(GLPG)$</a>&nbsp;市值37亿美元，账上有近50亿欧元。股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据：治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。<a target=\"_blank\" href=\"https://laohu8.com/S/03692\">$翰森制药(03692)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/IMAB\">$天境生物(IMAB)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/ADAG\">$天演药业(ADAG)$</a>&nbsp;<a target=\"_blank\" href=\"https://laohu8.com/S/CNTB\">$康乃德生物医药(CNTB)$</a>&nbsp;</body></html>","text":"$Galapagos NV(GLPG)$ 市值37亿美元，账上有近50亿欧元。 股价下跌是因为公布了口服SIK抑制剂GLPG3970治疗类风湿性关节炎（RA）的2a期试验数据： 治疗组的16名患者中有3名和安慰剂组的12名患者中有2名由于COVID-19和医生的决定等原因中止了试验。在第6周，服用GLPG3970的患者与安慰剂或其他大多数疗效终点没有区别。 $翰森制药(03692)$ $天境生物(IMAB)$ $天演药业(ADAG)$ $康乃德生物医药(CNTB)$","highlighted":1,"essential":1,"paper":2,"likeSize":14,"commentSize":1,"repostSize":1,"favoriteSize":0,"link":"https://laohu8.com/post/170308958","repostId":0,"isVote":1,"tweetType":1,"viewCount":6290,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["GLPG","ADAG","IMAB","03692","CNTB"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":352,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":5279161,"commentId":"5279161","gmtCreate":1626834803290,"gmtModify":1626834803290,"authorId":3573102416837786,"author":{"id":3573102416837786,"idStr":"3573102416837786","authorId":3573102416837786,"name":"小滴","avatar":"https://static.tigerbbs.com/db4a32287ea6634d9257724dc05b64f0","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":170308958,"objectIdStr":"170308958","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"[微笑]","text":"[微笑]","html":"[微笑]","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"hasMoreComment":true,"orderType":2}

市值低于现金的企业，是机会吗

评论（1）

热议股票